Annual CFO
-$48.50 M
+$15.92 M+24.71%
December 31, 2023
Summary
- As of February 8, 2025, BIOR annual cash flow from operations is -$48.50 million, with the most recent change of +$15.92 million (+24.71%) on December 31, 2023.
- During the last 3 years, BIOR annual CFO has risen by +$117.25 million (+70.74%).
- BIOR annual CFO is now at all-time high.
Performance
BIOR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$8.73 M
+$2.22 M+20.29%
September 30, 2024
Summary
- As of February 8, 2025, BIOR quarterly cash flow from operations is -$8.73 million, with the most recent change of +$2.22 million (+20.29%) on September 30, 2024.
- Over the past year, BIOR quarterly CFO has stayed the same.
- BIOR quarterly CFO is now at all-time high.
Performance
BIOR Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$45.92 M
+$2.30 M+4.78%
September 30, 2024
Summary
- As of February 8, 2025, BIOR TTM cash flow from operations is -$45.92 million, with the most recent change of +$2.30 million (+4.78%) on September 30, 2024.
- Over the past year, BIOR TTM CFO has stayed the same.
- BIOR TTM CFO is now -107.83% below its all-time high of -$22.10 million, reached on March 1, 2019.
Performance
BIOR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BIOR Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.7% | 0.0% | 0.0% |
| 3 y3 years | +70.7% | 0.0% | 0.0% |
| 5 y5 years | +25.5% | 0.0% | 0.0% |
BIOR Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +71.0% | at high | +78.2% | -3.1% | +72.6% |
| 5 y | 5-year | at high | +71.0% | at high | +87.7% | -3.1% | +77.8% |
| alltime | all time | at high | +71.0% | at high | +87.7% | -107.8% | +77.8% |
Biora Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.73 M(-20.3%) | -$45.92 M(-4.8%) |
| Jun 2024 | - | -$10.95 M(-12.4%) | -$48.23 M(-1.4%) |
| Mar 2024 | - | -$12.50 M(-9.1%) | -$48.90 M(+0.8%) |
| Dec 2023 | -$48.50 M(-24.7%) | -$13.74 M(+24.6%) | -$48.50 M(+6.0%) |
| Sep 2023 | - | -$11.03 M(-5.1%) | -$45.77 M(+2.8%) |
| Jun 2023 | - | -$11.62 M(-3.9%) | -$44.54 M(-15.3%) |
| Mar 2023 | - | -$12.10 M(+9.8%) | -$52.56 M(-18.4%) |
| Dec 2022 | -$64.42 M(-61.5%) | -$11.02 M(+12.4%) | -$64.42 M(-31.1%) |
| Sep 2022 | - | -$9.80 M(-50.1%) | -$93.44 M(-26.3%) |
| Jun 2022 | - | -$19.64 M(-18.0%) | -$126.83 M(-11.2%) |
| Mar 2022 | - | -$23.95 M(-40.2%) | -$142.88 M(-14.7%) |
| Dec 2021 | -$167.49 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | -$40.05 M(-7.3%) | -$167.49 M(-15.5%) |
| Sep 2021 | - | -$43.19 M(+21.0%) | -$198.12 M(-4.2%) |
| Jun 2021 | - | -$35.69 M(-26.5%) | -$206.79 M(+12.7%) |
| Mar 2021 | - | -$48.56 M(-31.3%) | -$183.42 M(+10.7%) |
| Dec 2020 | -$165.74 M(+56.2%) | -$70.68 M(+36.3%) | -$165.74 M(+17.6%) |
| Sep 2020 | - | -$51.86 M(+321.1%) | -$140.91 M(+26.0%) |
| Jun 2020 | - | -$12.32 M(-60.1%) | -$111.80 M(-2.7%) |
| Mar 2020 | - | -$30.89 M(-32.6%) | -$114.91 M(+8.3%) |
| Dec 2019 | -$106.12 M(+63.0%) | -$45.84 M(+101.5%) | -$106.12 M(+76.1%) |
| Sep 2019 | - | -$22.75 M(+47.5%) | -$60.28 M(+60.6%) |
| Jun 2019 | - | -$15.43 M(-30.2%) | -$37.53 M(+69.8%) |
| Mar 2019 | - | -$22.10 M | -$22.10 M |
| Dec 2018 | -$65.13 M | - | - |
FAQ
- What is Biora Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Biora Therapeutics?
- What is Biora Therapeutics annual CFO year-on-year change?
- What is Biora Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Biora Therapeutics?
- What is Biora Therapeutics quarterly CFO year-on-year change?
- What is Biora Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Biora Therapeutics?
- What is Biora Therapeutics TTM CFO year-on-year change?
What is Biora Therapeutics annual cash flow from operations?
The current annual CFO of BIOR is -$48.50 M
What is the all time high annual CFO for Biora Therapeutics?
Biora Therapeutics all-time high annual cash flow from operations is -$48.50 M
What is Biora Therapeutics annual CFO year-on-year change?
Over the past year, BIOR annual cash flow from operations has changed by +$15.92 M (+24.71%)
What is Biora Therapeutics quarterly cash flow from operations?
The current quarterly CFO of BIOR is -$8.73 M
What is the all time high quarterly CFO for Biora Therapeutics?
Biora Therapeutics all-time high quarterly cash flow from operations is -$8.73 M
What is Biora Therapeutics quarterly CFO year-on-year change?
Over the past year, BIOR quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Biora Therapeutics TTM cash flow from operations?
The current TTM CFO of BIOR is -$45.92 M
What is the all time high TTM CFO for Biora Therapeutics?
Biora Therapeutics all-time high TTM cash flow from operations is -$22.10 M
What is Biora Therapeutics TTM CFO year-on-year change?
Over the past year, BIOR TTM cash flow from operations has changed by $0.00 (0.00%)